ClinConnect ClinConnect Logo
Search / Trial NCT00733109

Management of Cervical Intraepithelial Neoplasia Grade 2

Launched by UNIVERSIDADE CIDADE DE SAO PAULO · Aug 11, 2008

Trial Information

Current as of May 01, 2025

Completed

Keywords

Cin2 Management

ClinConnect Summary

Pap smear and colposcopy were performed at every follow-up visit and all lesions were completely visible at colposcopy.

The researchers purpose was to make some comments about the over treatment and the misclassification of CIN 2.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Histological CIN2 diagnosis
  • Exclusion Criteria:
  • Previous CIN treatment

About Universidade Cidade De Sao Paulo

Universidade Cidade de São Paulo (UCSP) is a distinguished academic institution dedicated to advancing medical research and clinical trials. With a commitment to innovation and excellence, UCSP leverages its multidisciplinary expertise to facilitate groundbreaking studies that address critical health challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. Through its rigorous research initiatives, UCSP aims to contribute valuable insights to the medical community and improve patient outcomes on a global scale.

Locations

São Paulo, , Brazil

Patients applied

0 patients applied

Trial Officials

Sylvia F Brenna, MD, PhD

Principal Investigator

Universidade Cidade de Sao Paulo

Ana C Guedes, MD, PhD

Principal Investigator

Universidade Cidade de Sao Paulo

Kari J Sirjanen, MD, PhD

Study Chair

University of Turku

Luis C Zeferino, MD, PhD

Study Director

University of Campinas, Brazil

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials